November is Lung Cancer Awareness month, and for good reason: lung cancer is the number one cause of cancer death in the US. While lung cancer has multiple causes, about 85% of cases are associated with long-term tobacco smoking.
Now there’s Axumin (fluciclovine F 18), an FDA-approved positron emission tomography (PET) scan that works by analyzing the metabolic activity specific to prostate cancer. PET is a nuclear medicine imaging test that utilizes a tiny amount of radioactive material, called a radiotracer, that is attracted to tumor cells, enabling earlier cancer discovery than many other types of scans.
For most people, hearing the word “biopsy” is unsettling. Luckily, most biopsies turn out to be negative, meaning there are no signs of cancer. Infection, internal injury and other diseases can create similar symptoms, so when your doctor or clinician orders a biopsy, it is important to get checked out as quickly as possible.